-
Q4 EPS Estimate for ARS Pharmaceuticals Boosted by Analyst
Источник: Buzz FX / 15 ноя 2024 10:41:18 America/New_York
Q4 EPS Estimate for ARS Pharmaceuticals Boosted by Analyst Written by MarketBeat November 15, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Free Report ) - Research analysts at William Blair boosted their Q4
Read more...